Latest Insider Transactions at Hanover Insurance Group, Inc. (THG)
This section provides a real-time view of insider transactions for Hanover Insurance Group, Inc. (THG). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of HANOVER INSURANCE GROUP, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of HANOVER INSURANCE GROUP, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 27
2025
|
David John Lovely Executive Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
12
+0.53%
|
-
|
|
Jun 27
2025
|
Willard T Lee Executive Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
12
+0.22%
|
-
|
|
Jun 27
2025
|
Denise Lowsley Executive Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
12
+0.24%
|
-
|
|
Jun 27
2025
|
Bryan J Salvatore Executive Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
29
+0.11%
|
-
|
|
Jun 27
2025
|
John C Roche President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
140
+0.11%
|
-
|
|
Jun 27
2025
|
Jeffrey M Farber Executive Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
51
+0.11%
|
-
|
|
Jun 27
2025
|
Richard W Lavey Executive Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
32
+0.08%
|
-
|
|
Jun 27
2025
|
Dennis Francis Kerrigan Executive Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
18
+0.18%
|
-
|
|
May 23
2025
|
Jane D Carlin Director |
SELL
Open market or private sale
|
Direct |
977
-100.0%
|
$163,159
$167.81 P/Share
|
|
May 14
2025
|
Kevin Bradicich Director |
BUY
Grant, award, or other acquisition
|
Direct |
977
+9.55%
|
-
|
|
May 14
2025
|
Cynthia Egan Director |
BUY
Grant, award, or other acquisition
|
Indirect |
977
+50.0%
|
-
|
|
May 14
2025
|
Francisco Aristeguieta Director |
BUY
Grant, award, or other acquisition
|
Direct |
977
+18.84%
|
-
|
|
May 14
2025
|
Theodore H Bunting Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
977
+13.64%
|
-
|
|
May 14
2025
|
Jane D Carlin Director |
BUY
Grant, award, or other acquisition
|
Direct |
977
+50.0%
|
-
|
|
May 14
2025
|
J Paul Condrin Director |
BUY
Grant, award, or other acquisition
|
Direct |
977
+15.06%
|
-
|
|
May 14
2025
|
Kathy S Lane Director |
BUY
Grant, award, or other acquisition
|
Indirect |
977
+16.83%
|
-
|
|
May 14
2025
|
Joseph R Ramrath Director |
BUY
Grant, award, or other acquisition
|
Direct |
977
+2.88%
|
-
|
|
May 14
2025
|
Elizabeth A Ward Director |
BUY
Grant, award, or other acquisition
|
Direct |
977
+16.25%
|
-
|
|
May 14
2025
|
William E. Donnell Director |
BUY
Grant, award, or other acquisition
|
Indirect |
977
+50.0%
|
-
|
|
May 07
2025
|
Bryan J Salvatore Executive Vice President |
SELL
Open market or private sale
|
Direct |
10,526
-10.47%
|
$1,747,316
$166.96 P/Share
|
|
May 07
2025
|
Bryan J Salvatore Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
10,526
+22.44%
|
$863,132
$82.39 P/Share
|
|
Apr 01
2025
|
John C Roche President and CEO |
SELL
Open market or private sale
|
Direct |
8,906
-6.68%
|
$1,558,550
$175.17 P/Share
|
|
Apr 01
2025
|
John C Roche President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
8,906
+6.26%
|
$685,762
$77.91 P/Share
|
|
Mar 31
2025
|
John C Roche President and CEO |
SELL
Open market or private sale
|
Direct |
301
-0.24%
|
$52,675
$175.0 P/Share
|
|
Mar 31
2025
|
John C Roche President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
301
+0.24%
|
$23,177
$77.91 P/Share
|
|
Mar 28
2025
|
Denise Lowsley Executive Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
11
+0.22%
|
-
|
|
Mar 28
2025
|
David John Lovely Executive Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
11
+0.49%
|
-
|
|
Mar 28
2025
|
John C Roche President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
135
+0.11%
|
-
|
|
Mar 28
2025
|
John C Roche President and CEO |
SELL
Open market or private sale
|
Direct |
400
-0.32%
|
$70,000
$175.03 P/Share
|
|
Mar 28
2025
|
John C Roche President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
400
+0.32%
|
$30,800
$77.91 P/Share
|
|
Mar 28
2025
|
Bryan J Salvatore Executive Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
28
+0.11%
|
-
|
|
Mar 28
2025
|
Dennis Francis Kerrigan Executive Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
17
+0.17%
|
-
|
|
Mar 28
2025
|
Richard W Lavey Executive Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
31
+0.08%
|
-
|
|
Mar 28
2025
|
Willard T Lee Executive Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
12
+0.22%
|
-
|
|
Mar 28
2025
|
Jeffrey M Farber Executive Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
50
+0.11%
|
-
|
|
Mar 27
2025
|
John C Roche President and CEO |
SELL
Open market or private sale
|
Direct |
200
-0.16%
|
$35,000
$175.01 P/Share
|
|
Mar 27
2025
|
John C Roche President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
200
+0.16%
|
$15,400
$77.91 P/Share
|
|
Mar 26
2025
|
John C Roche President and CEO |
SELL
Open market or private sale
|
Direct |
900
-0.72%
|
$157,500
$175.17 P/Share
|
|
Mar 26
2025
|
John C Roche President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
900
+0.71%
|
$69,300
$77.91 P/Share
|
|
Mar 03
2025
|
John C Roche President and CEO |
SELL
Open market or private sale
|
Direct |
10,706
-2.71%
|
$1,830,726
$171.81 P/Share
|
|
Mar 03
2025
|
John C Roche President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,706
+7.35%
|
$824,362
$77.91 P/Share
|
|
Mar 03
2025
|
Bryan J Salvatore Executive Vice President |
SELL
Open market or private sale
|
Direct |
10,526
-10.63%
|
$1,799,946
$171.79 P/Share
|
|
Mar 03
2025
|
Bryan J Salvatore Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
10,526
+22.45%
|
$863,132
$82.39 P/Share
|
|
Feb 28
2025
|
Bryan J Salvatore Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
1,836
-6.64%
|
$312,120
$170.53 P/Share
|
|
Feb 28
2025
|
Willard T Lee Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
770
-12.39%
|
$130,900
$170.53 P/Share
|
|
Feb 28
2025
|
Jeffrey M Farber Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
3,682
-7.44%
|
$625,940
$170.53 P/Share
|
|
Feb 28
2025
|
John C Roche President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
8,826
-6.63%
|
$1,500,420
$170.53 P/Share
|
|
Feb 28
2025
|
Denise Lowsley Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
832
-14.21%
|
$141,440
$170.53 P/Share
|
|
Feb 28
2025
|
Dennis Francis Kerrigan Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
1,180
-10.58%
|
$200,600
$170.53 P/Share
|
|
Feb 28
2025
|
Richard W Lavey Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
1,917
-4.68%
|
$325,890
$170.53 P/Share
|